期刊文献+

HCV实验动物模型研究进展 被引量:4

Progress in the development of experimental animal models of HCV infection
下载PDF
导出
摘要 HCV是威胁人类健康的重要病原体之一,可在人体肝脏形成持续性感染,导致慢性肝炎、肝纤维化、肝硬化和肝癌。HCV的实验动物模型不仅是HCV免疫学、病理学和病毒学等基础科学的重要研究手段,还为HCV疫苗和药物的研发提供了关键的工具和平台。黑猩猩是除了人类以外唯一可以被HCV感染的灵长类动物,为HCV的研究做出了重要贡献,但其使用受到了成本及伦理上的限制。近年在利用树鼩和人源化小鼠建立HCV小动物模型的研究上取得良好的进展。本文将总结常用HCV实验动物模型的现状和挑战。 HCV is one of the major pathogens that pose threats to human public health. It can establish persistent infection in human liver, leading to chronic hepatitis, liver fibrosis/cirrhosis and hepatocellular carcinoma. The experimental animal models for HCV infection are not only important research means for investigating immunology, pathology and virology of HCV infection, but also serve as the means and platform for the development of HCV vaccines and novel agents. Chimpanzees, the sole primate except hu- man beings who can be infected by HCV, have made significant contributions to HCV research. However, their application has been hampered due to their cost and ethical issues. A big progress has been made in developing small animal models for HCV research using tupaia and humanized mice in recent years. This review summarizes the current status and challenges of the development of HCV animal models.
出处 《传染病信息》 2012年第2期71-74,共4页 Infectious Disease Information
基金 上海巴斯德健康研究基金(SPHRF2009001)
关键词 丙型肝炎病毒 模型 动物 黑猩猩 树鼩 人源化小鼠 hepaeivirus models, animal chimpanzees tupaia humanized mice
  • 相关文献

参考文献31

  • 1Choo QL,Kuo G,Weiner AJ,et al.Isolation of a cDNA clone derived from a blood-borne non-A,non-B viral hepatitis genome[J].Science,1989,244(4902):359-362.
  • 2Kolykhalov AA,Agapov EV,Blight KJ,et al.Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA[J].Science,1997,277(5325):570-574.
  • 3Yanagi M,Purcel RH,Emerson SU,et al.Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee[J].Proc Natl Acad Sci U S A,1997,94(16):8738-8743.
  • 4Shimizu YK,Weiner AJ,Rosenblatt J,et al.Early events in hepatitis C virus infection of chimpanzees[J].Proc Natl Acad Sci U S A,1990,87(16):6441-6444.
  • 5Walter E,Keist R,Niederst B,et al.Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo[J].Hepatology,1996,24(1):1-5.
  • 6Xie ZC,Riezu-Boj JI,Lasarte JJ,et al.Transmission of hepatitis C virus infection to tree shrews[J].Virology,1998,244(2):513-520.
  • 7Xu X,Chen H,Cao X,et al.Efficient infection of tree shrew(Tupaia belangeri)with hepatitis C virus grown in cell culture or from patient plasma[J].J Gen Virol,2007,88(Pt9):2504-2512.
  • 8Amako Y,Tsukiyama-Kohara K,Katsume A,et al.Pathogenesis of hepatitis C virus infection in Tupaia belanger[iJ].J Virol,2010,84(1):303-311.
  • 9Tong Y,Zhu Y,Xia X,et al.Tupaia CD81,SR-BI,Claudin-1,and occludin support hepatitis C virus infection[J].J Virol,2011,85(6):2793-2802.
  • 10Moriya K,Fujie H,Shintani Y,et al.The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice[J].Nat Med,1998,4(9):1065-1067.

同被引文献49

  • 1EdwinC.Ouyang,CatherineH.Wu,CherieWalton,KittichaiPromrat,GeorgeY.Wu.Transplantation of human hepatocytes into tolerized genetically immunocompetent rats[J].World Journal of Gastroenterology,2001,7(3):324-330. 被引量:23
  • 2WHO. Guidelines for the screening, care and treatment of persons with hepatitis C infection[ M]. WHO Press, 2014: 5 -122.
  • 3SMITH DB, BUKH J, KUIKEN C, et al. Expanded classifica- tion of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource[ J ]. Hepatology, 2014, 59(1 ) : 318 -327.
  • 4THOMAS DL. Global control of hepatitis C: where challenge meets opportunity[J]. Nat Med, 2013, 19(7) : 850 -858.
  • 5MANNS MP, von HAHN T. Novel therapies for hepatitis C -one pill fits all? [J]. Nat Rev Drug Discov, 2013, 12(8): 595 -610.
  • 6ENOMOTO N, SAKUMA I, ASAHINA Y, et al. Comparison of full- length sequences of interferon -sensitive and resist- ant hepatitis C virus 1 b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region[J]. J Clin In- vest, 1995, 96(1): 224-230.
  • 7RAO H, WEI L, LOPEZ -TALAVERA JC, et al. Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection [ J ]. J Gastro- enterol Hepatol, 2014, 29(3): 545-553.
  • 8SHI X, PAN Y, WANG M, et al. IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese popu- lation[J]. PLoS One, 2012, 7(5) : e37054.
  • 9THOMAS DL, THIO CL, MARTIN MP, et al. Genetic varia- tion in IL28B and spontaneous clearance of hepatitis C virus [J]. Nature, 2009, 461 (7265):798-801.
  • 10TANAKA Y, NISHIDA N, SUGIYAMA M, et al. Genome - wide association of IL28B with response to pegylated inter- feron -alpha and ribavirin therapy for chronic hepatitis C [ J ]. Nat Genet, 2009, 41 (10) : 1105 -1109.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部